From: Immune ablation and stem-cell therapy in autoimmune disease - Clinical experience
Disease
Clinical response
MS
SSc
RA
JIA
SLE
Evaluated
75
33
35
25
14
Better
24
21
16
10
Stable
27
3
2
1
0
Better than progressed
7
13
Worse
17
6